Taiwan earmarks $755M for multi-year drug supply resilience program
The three-pronged plan to strengthen domestic drug supply will be supported by an investment of 24 billion new Taiwan dollars ($755 million), President Lai Ching-te said.
Forma Life Sciences launches with oral solid dose focus, joining class of new CDMOs
Forma Life Sciences, which inherited BioDuro’s California operations earlier this year, officially launched as a CDMO with a focus on oral solid dosage drugs this week.
BioDuro enters Taiwan joint venture, adding commercial API plant to production network
BioDuro, headquartered in California, has set up a new joint venture with Taiwan drug ingredients manufacturer, Cenra API Solutions. The new enterprise will see Cenra’s commercial-scale facility in Taipei folded into BioDuro’s
CDMO Quotient extends Ipsen supply pact for rare disease drug Sohonos
Quotient Sciences, a CDMO that specializes in “niche and smaller volume” drugs, has extended a deal with Ipsen to manufacture Sohonos (palovarotene) capsules. Sohonos is currently the only medication approved by the
Why Digital Tool are Needed to Cope with Increasing Pressures in MedTech Innovation
MTI Viewpoint Insights shared by industry relative to healthcare and the advancement of medical technology. Rene Zoelfl is Global Industry Advisor Life Science, supports life science companies in their transformation towards greater agility
Merck to wind down Gardasil production at N.C. plant, lay off 150-plus
In a Worker Adjustment and Retraining Notification Act alert filed this week, Merck revealed that it is laying off 147 staffers at a vaccine manufacturing plant in Durham. The cuts are a
Decision Criteria for Technology Commercialization of Medical Devices in 2026
The successful commercialization of innovative medical technologies remains a cornerstone of advancing healthcare delivery and patient outcomes. The journey from a novel concept to a market-ready product is fraught with complexity, requiring
Viatris to cut 10% of workforce in 3-year overhaul, discloses fire at India plant
Viatris’ three-year reorganization will affect staffers in a range of functions including the company’s commercial teams, R&D, medical affairs and manufacturing. Besides the layoffs, the drugmaker also reported a fire in India.
AbbVie advances US expansion with $380M for 2 new North Chicago API plants
The new plants are the latest in a string of recent investments AbbVie has made in U.S. manufacturing, filling out the company’s plan to infuse $100 billion into its American operations over
CDMO Bora locks in 5-year, $250M production agreement with GSK
With a productive working relationship between the two companies already well established, Bora Pharmaceuticals is renewing a $250 million global manufacturing agreement with British drugmaker GSK.